Medicinershoppen ApS Financials, key figures and credit report
Net sales 518.2 kDKK FY 2025 -24.8% vs 2024
EBIT margin 29.5 % FY 2025 -0 pp vs 2024
Net debt - 200.1 kDKK FY 2025 -5.2% vs 2024
Quick ratio 3 357.2 FY 2025 +3,353.8 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 568.71 | 509.42 | 496.32 | 689.16 | 518.18 |
| Costs of manufacturing | - 158.40 | - 189.98 | - 277.72 | - 319.73 | - 258.69 |
| External services | - 190.75 | - 268.76 | -53.16 | - 115.47 | -70.23 |
| Rents | -3.93 | ||||
| Gross profit | 219.57 | 50.67 | 138.45 | 212.70 | 156.74 |
| Costs of management | -23.06 | -41.26 | -32.51 | ||
| Total depreciation | -15.91 | -2.41 | -1.67 | ||
| EBIT | 219.57 | 50.67 | 117.55 | 203.40 | 152.70 |
| Other financial income | 0.20 | ||||
| Other financial expenses | -0.76 | ||||
| Income from other inv. held as non-curr. assets | 0.20 | ||||
| Pre-tax profit | 219.57 | 50.67 | 117.55 | 203.81 | 151.94 |
| Income taxes | -48.31 | -11.15 | -25.86 | -44.84 | -33.43 |
| Net earnings | 171.27 | 39.52 | 91.69 | 158.97 | 118.51 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 102.53 | 109.07 | 128.99 | 110.66 | 162.07 |
| Inventories total | 102.53 | 109.07 | 128.99 | 110.66 | 162.07 |
| Current trade debtors | 1.28 | ||||
| Current other receivables | 0.00 | ||||
| Short term receivables total | 1.29 | ||||
| Cash and bank deposits | 182.09 | 195.23 | 189.71 | 190.21 | 200.15 |
| Cash and cash equivalents | 182.09 | 195.23 | 189.71 | 190.21 | 200.15 |
| Balance sheet total (assets) | 284.62 | 304.30 | 318.70 | 300.87 | 363.50 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | - 124.00 | - 158.12 | 225.00 | ||
| Retained earnings | 171.00 | 236.39 | 204.08 | -20.07 | |
| Profit of the financial year | 171.27 | 39.52 | 91.69 | 158.97 | 118.51 |
| Shareholders equity total | 211.27 | 250.53 | 244.08 | 244.93 | 363.44 |
| Non-current liabilities total | |||||
| Other non-interest bearing current liabilities | 73.35 | 53.78 | 74.62 | 55.94 | 0.06 |
| Current liabilities total | 73.35 | 53.78 | 74.62 | 55.94 | 0.06 |
| Balance sheet total (liabilities) | 284.62 | 304.30 | 318.70 | 300.87 | 363.50 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated